Categories: HealthcareNews

Remedium Healthcare Products Launches NuVeria Labs’ Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime

Remedium Healthcare Products announces the launch of NuVeria Labs’ Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound care

NORTHBROOK, Ill., April 19, 2024 (GLOBE NEWSWIRE) — Remedium Healthcare Products is proud to announce the launch of NuVeria Labs’ revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers’ doorsteps.

Designed to address the unique challenges of wound care in both clinical and home settings, NuVeria Labs’ Sacral Silicone Dressing is engineered with precision and backed by extensive clinical research. Featuring a patented design and shape that conforms seamlessly to the curvature of the sacrum, this innovative dressing provides superior performance, enhanced comfort, and prolonged wearability, setting a new standard in prevention and wound treatment.

Remedium Healthcare Products launches NuVeria Labs’ Sacral Silicone Dressing on Amazon.

“Our commitment at Remedium Healthcare Products is to provide patients and caregivers with innovative and effective healthcare solutions,” said Vlad Anastasov, President of Remedium Healthcare Products. “The launch of NuVeria Labs brand on Amazon is a testament to this commitment, offering convenient access to high-quality wound care products for consumers nationwide.”

NuVeria Labs’ by Remedium Healthcare Products demonstrates a shared dedication to bridging the gap between clinical efficacy and accessibility. Patients and caregivers can now easily purchase this innovative product online and experience the high standard of care and comfort previously only available in clinical environments.

“We believe that everyone should have access to reliable and effective wound care solutions, regardless of where they are receiving treatment,” added Vlad Anastasov. “With NuVeria Labs’ Silicone Foam Dressings, we are making high-quality wound care and knowledge accessible to everyone, with just a few clicks.”

Whether you’re a healthcare professional seeking superior wound care solutions or a patient in need of reliable and comfortable dressing, NuVeria Labs Silicone Dressing is your trusted companion on the journey to healing. Experience the difference today and discover why NuVeria Labs, under the ownership of Remedium Healthcare Products, is the preferred choice for innovative wound care solutions.

To purchase NuVeria Labs’ Sacral Silicone Foam Dressing on Amazon, visit

Amazon.com: NuVeria Labs Sacral Bordered Silicone Foam Wound Dressing – Gentle Silicone Adhesive Helps minimize discomfort, 7.1 x 6.5″ Sacrum-Shaped, 5 Each/Box : Industrial & Scientific

Amazon.com: NuVeria Labs Sacral Bordered Silicone Foam Wound Dressing – Gentle Silicone Adhesive Helps minimize discomfort, 9 x 8″ Sacrum-Shaped, 5 Each/Box : Industrial & Scientific

For more information about Remedium Healthcare Products and its ownership of the NuVeria Labs brand, visit www.remedium-usa.com or contact us at info@remedium-usa.com

About Remedium Healthcare Products:

Remedium Healthcare Products is a trusted provider of innovative skin health solutions, dedicated to improving patient outcomes through advanced technology and clinical expertise. As the owner of the NuVeria Labs brand, Remedium Healthcare Products is committed to providing consumers with high-quality, and accessible healthcare products that focus on skin health and enhance their well-being.

Contact:

Remedium PR Team

Remedium Healthcare Products

+1 888-485-4465

info@remedium-usa.com

www.remedium-usa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5f1a6fe0-f43a-44a0-81b5-adfae4adf515

Staff

Recent Posts

Discover the Holistic Bliss of Good Organics CBD 

As Stress Awareness Month is here this April and Mental Health Awareness Month follows in…

28 mins ago

Vaxxinity Issues Shareholder Letter

CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the…

3 hours ago

Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative…

3 hours ago

FendX Announces Corporate Update

Oakville, Ontario--(Newsfile Corp. - April 19, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

17 hours ago

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

ZÜRICH, SWITZERLAND / ACCESSWIRE / April 19, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or…

18 hours ago

Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K

CHICAGO, IL / ACCESSWIRE / April 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or…

18 hours ago